PTC (NASDAQ:PTC – Get Free Report) was downgraded by stock analysts at StockNews.com from a “buy” rating to a “hold” rating ...

Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) have been given an average recommendation of “Moderate Buy” ...

Shares of PTC Inc. PTC shed 2.36% to $153.30 Thursday, on what proved to be an all-around poor trading session for the stock ...

We came across a bullish thesis on PTC Inc. (PTC) on Twitter by TMTMoats. In this article, we will summarize the bulls’ ...

The stock's rise snapped a four-day losing streak.

PTC (NasdaqGS:PTC) experienced a 4.52% decline in its total shareholder returns over the past week, coinciding with the appointment of Trac Pham to its Board of Directors. Pham brings a strong record ...

Citi analyst Geoff Meacham raised the firm’s price target on PTC Therapeutics (PTCT) to $50 from $46 and keeps a Sell rating on the shares ...

Indian oil explorer Oil and Natural Gas Corp said on Tuesday its unit acquired clean energy firm PTC Energy for 9.25 billion ...

PTC Therapeutics could boost revenue with vatiquinone for Friedreich's ataxia. Find out why PTCT stock is poised for growth ...

It has been about a month since the last earnings report for PTC Inc. (PTC). Shares have lost about 6.4% in that time frame, underperforming the S&P 500. Will the recent negative trend continue ...

Learn more about whether Samsara Inc. or PTC Inc. is a better investment based on AAII's A+ Investor grades, which compare ...

In a report released today, Saket Kalia from Barclays maintained a Buy rating on PTC (PTC – Research Report), with a price target of $215.00.